Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100299392 | 10029939 | 2 | F | 20131022 | 20141224 | 20140323 | 20141231 | EXP | GB-MHRA-EYC 00109422 | GB-009507513-1403GBR009864 | MERCK | 41.00 | YR | M | Y | 78.92000 | KG | 20141231 | N | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100299392 | 10029939 | 1 | PS | PROPECIA | FINASTERIDE | 1 | ORAL | 1 MG, QD | 1172 | MG | U | 20788 | 1 | MG | FILM-COATED TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100299392 | 10029939 | 1 | Alopecia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100299392 | 10029939 | OT |
| 100299392 | 10029939 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100299392 | 10029939 | Balance disorder | |
| 100299392 | 10029939 | Dizziness | |
| 100299392 | 10029939 | Gait disturbance | |
| 100299392 | 10029939 | Holmes-Adie pupil | |
| 100299392 | 10029939 | Labyrinthitis | |
| 100299392 | 10029939 | Mydriasis | |
| 100299392 | 10029939 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100299392 | 10029939 | 1 | 20100808 | 20131023 | 0 |